What if you could read the DNA of your future child? | Noor Siddiqui

0:02You're listening to TED Talks Daily, where we bring you new ideas to spark your curiosity every day. I'm your host, Elise Hu. For all of human history, a baby's DNA has been determined by chance at conception, the so-called genetic lottery.

0:17Noor Siddiqui: For 300 ,000 years, every parent in human history handed their child a genetic hand they'd never seen. There was no way to know what was in it, no way to prepare, and no way to choose health. The genetic lottery ran, and you got what you got. That era is over. That's reproductive technology researcher Noor Siddiqui. Her company, Orchid, builds screening tools to read the whole genome of embryos. It's in an effort to give parents more genetic information than standard IVF. It's an idea that excites some people and deeply worries others. Noor is an advocate for it, and her own motivation is personal.

0:59Noor Siddiqui: I grew up watching my mom go blind. It took years just to get the diagnosis. And after all the testing and all the office visits and all the uncertainty, the answer was, there's nothing we can do. In her talk, Noor makes the case that this technology can help families understand and reduce health risks before a child is born. But the implications for ethics, for access, for how far this should go are profound and far from settled. That's coming up next, and stick around after the talk for a brief conversation between Noor and TED's vision steward, Sal Khan. All this right after a short break.

1:51studying how people think and what it actually takes to change our minds. It's work I find deeply meaningful. But even in meaningful work, there's still busy work. The admin, the repetitive processes, the invisible load that pulls attention away from what really matters. That's where ServiceNow's AI specialists come in. They don't just tell you what you should do about your busy work. They actually do it. Start to finish. Cases closed. Requests handled. No extra work for you. To learn how to put AI to work for people, visit servicenow.com.

2:25This message is brought to you by Apple Card. Ah, fall, that cozy season where we swap the swimwear for sweaters and sunnies for scarves. But before the Halloween decorations are put away or the Thanksgiving table has been set, there's already holly jolly music playing in the grocery store, reminding you that the year is coming to a close. Time to kick end of year into high gear. When you use Apple Card with Apple Pay, you earn 2 % daily cash back on all purchases, including food, decorations, gifts, and more. Get a head start on your end-of-year purchases. Apply for your Apple Card in the Wallet app on your iPhone today and start using it right away with Apple Pay.

3:06Subject to credit approval, Apple Card is issued by Goldman Sachs, Bank USA, Salt Lake City Branch, Terms and more at AppleCard.com. This episode is brought to you by Walmart Business. The best leaders might tell you the work that moves an organization forward doesn't happen in spreadsheets or supply chain emails. It happens when you have the space to think big. That's the idea behind Walmart Business. It's built to take the friction out of running an organization so your team isn't losing hours to procurement logistics when they could just be focused on the problems that actually matter. With an ever-expanding business assortment, everyday low prices, and fast, reliable shipping, Walmart Business keeps your operations running smoothly.

3:47Shop online, in-store, or through the Walmart Business app. However works best for you. Simpler operations, smarter spending. It's Walmart built for your business. Sign up for a free Walmart business account at business.walmart.com.

4:08And now, our TED Talk of the day.

4:11Noor Siddiqui: For 300 ,000 years, every parent in human history handed their child a genetic hand they'd never seen. There was no way to know what was in it, no way to prepare, and no way to choose health. The genetic lottery ran, and you got what you got. That era is over. and the way that we have babies is changing forever. But before we get into that, I want to start with you and how you got here. You began as two cells, an egg and a sperm, each carrying 23 chromosomes. When that egg and sperm met, sparks literally flew. A burst of zinc emerged to start your life. And this specific moment locked in your entire genetic destiny.

4:56Noor Siddiqui: Your mother produced two million eggs, your father produced over 500 billion sperm, and the specific combination of egg and sperm that make up you is a one in a trillion chance. The odds of you existing at all are about the same as picking one specific grain of sand out of all the grains of sand on all the beaches on the entire planet. You are wildly unlikely to exist at all. A different night, a different day, and it wouldn't have been you. Yet, tucked inside that miracle for hundreds of millions of people is a genetic disease waiting to take something from them. Their heart, their sight, their child.

5:40Noor Siddiqui: Something that will arrive regardless of how loved they are or how hard they fight. I grew up watching my mom go blind. It took years just to get the diagnosis. And after all the testing and all the office visits and all the uncertainty, the answer was, there's nothing we can do. She lost her night vision first, then her peripheral vision, and then finally and slowly, her central vision too. It sucks to be powerless. It sucks to watch someone you love so much lose something so precious. And unfortunately, she's not alone. 400 million people around the world suffer from genetic disease. That's more than the entire population of the United States.

6:26Noor Siddiqui: Half of those people that are affected are children. 95 % of those don't have an FDA-approved treatment. Scientists have now catalogued over 3 ,000 genetic diseases. You can't pronounce most of them. You don't know their names. but the people who are affected, who are living it day in and day out, they wouldn't wish it on their worst enemies. I started ORCID because of my mom. I still can't accept the fact that she's not going to be able to see her grandkids' faces because of a random genetic typo in her DNA. I built this because I don't want my own kids to be stuck with their life getting hijacked by a random genetic typo.

7:08Noor Siddiqui: We are the first company in the world to be able to sequence the entire genome of an embryo created during IVF. A round of IVF creates anywhere from five to 15 embryos. And today, that incredibly critical decision is made either by a beauty contest, what these embryos look like under a microscope, or they're made with a tiny slice of genetic information that's actually available. They zoom in on a specific chromosome. Are both chromosomes present or not? If they're missing, it'll let you know. And if both are present, it'll tell you you're all good. And if there's an extra chromosome, 21, for example, that's called trisomy 21 or Down syndrome.

7:46Noor Siddiqui: But the way you need to think about this is that you have 3 billion bases in your genome, and it's organized like a book. So those 3 billion bases are in 23 different chapters, and all this chromosome testing is able to do is tell you if every chapter is present or not. It's not actually reading any of the letters in any of those chapters. So if in chapter 7 or chromosome 7, there's a typo, there's a spelling error, it's not going to be able to find it. It's just going to tell you, hey, you know, chapter 7's all good. I only checked at the chapter level. So that's where whole genome sequencing becomes incredibly valuable because it's actually reading every single letter, all three billion of them.

8:28Noor Siddiqui: So what does that actually look like? So if you zoom into a specific chromosome, you're going to see a bunch of letters. And hidden in those three billion letters is a typo. And unfortunately, just a few letters can be the difference between a child that will never be able to talk and one that will. That's all that it takes, is a few letters changed. The reason that it's really hard to do this, and we're the first to do it in the world, is because embryos have extremely small quantities of DNA. The embryologist only sends us five cells, and in those five cells, there's 30 picograms of DNA. A picogram is a trillionth of a gram.

9:08Noor Siddiqui: So we're working with extremely tiny amounts of material, and we had to invent an entirely new technology to amplify or copy that DNA hundreds and thousands of times without corrupting it. Now we know that it works because we have embryos and we have the subsequent babies that were born nine months later, and we've matched them up, and we know that they match. So cool technology, what does it actually let parents do? So what's really exciting is that at the most basic level, what we're able to do is allow parents to understand and screen for those 3 ,000 diseases that we talked about. Birth defects, heart defects, skeletal defects, neurodevelopmental disorders, genetic forms of autism, all genetic diseases that are completely missed by existing testing.

9:53Noor Siddiqui: But we can go even further than that. Think about schizophrenia or bipolar disorder or heart disease, these are diseases that are driven by the cumulative impact of many millions of variants working together. Some people are at high genetic predisposition, and other people aren't. So what's amazing and what's available now is that now we have data from hundreds of thousands of individuals, we have their sequence data, and we have their medical records, so we can build models that quantify disease risk at the embryo level. So we can tell parents this embryo is at a high genetic predisposition, and this embryo is at a low genetic predisposition.

10:30Noor Siddiqui: And despite the fact that these models have millions of variants inside them, someone who's going through an IVF cycle who has only five embryos can expect to see anywhere from a 30 to 50 percent risk reduction with just those five embryos. And today, the models are the worst they're ever going to perform because we have the least data that we're ever going to have. Every year, we're getting more and more data, and these models are getting more and more powerful, which is going to translate to parents being able to reduce more risk with fewer embryos. And the best part is, this isn't sci-fi. These babies are actually already here.

11:04Noor Siddiqui: They're being photographed by the New York Times, and they're making international news. Because their parents have done something that has never been possible before. We are the first generation, the first life form, to be able to read its own source code and actually choose the next generation. We are the first to get to choose health, not just have to hope for it. Soon, this is going to be the default way we all have babies. And here's the thing most people don't realize yet. Sex is for fun, and embryo screening is for babies. Those two things have quietly separated, and once you see it that way, the question doesn't become, why would anyone do IVF electively?

11:48Noor Siddiqui: The question is, why would you do it any other way? I want you to meet someone. This is Mia. Mia was born with less encephaly, a terminal brain disorder. Most children with her condition don't make it to their 10th birthday. There was a genetic mutation, no cure, and no warning. Mia's mom did all the genetic testing that you've heard of, carrier screening, NIPT, and because those tests only evaluate less than 1 % of the genome, they're not able to identify the vast majority of these genetic diseases that we're talking about. There was no way for her to know. She used Orchid to screen her next embryos.

12:23Noor Siddiqui: She's pregnant now. And despite living with the tragedy of Mia's diagnosis, she's able to go into this next pregnancy more confident and with a little bit more security that her next child isn't going to have to suffer in the same way that Mia does. Same mother, same love, different outcome. Not because of luck, because of a choice. It can be hard to understand just how powerful a single base pair can be. Think about the tallest woman on Earth. She's over seven feet tall. And the shortest woman on Earth, and she's just over two feet tall. The tallest woman has a condition called Weaver's syndrome, and the shortest woman has a condition called achondroplasia.

13:03Noor Siddiqui: Both of these diseases are actually caused by one letter changed in three billion letters. And I think that's miraculous. That one letter can have such a dramatic difference. they're also both spontaneous mutations. So what that means is that there's no one else in their family that has these typos. They're the first ones to have them. You know, women get a lot of, you know, flack for their eggs aging, but something that men usually don't know is that sperm actually accumulates mutations as men age as well. And there's actually a whole category of genetic diseases that are just caused by mutations in sperm that don't affect men, and one of them is achondroplasia, one of the most common causes of dwarfism.

13:47Noor Siddiqui: So the genetic lottery doesn't only deal risk. It also deals some superpowers. This is a Finnish Olympic skier. He has a single base pair change in a gene that controls red blood cell production. So that means that his muscles get way more oxygen than his competitors. He has way more endurance and is practically unbeatable during his reign. There's a family in the Midwest that has eight times the bone density of anyone else that has been documented, and their bones are virtually unbreakable. You and I have only three color receptors, but there have been women found who have four color receptors.

14:25Noor Siddiqui: So while you and I can only see a million colors, they can see 100 million. They're living in a world that we literally can't picture. Extra endurance, unbreakable bones, 100 million colors. These aren't science fiction. They're already here. They're just currently given out by a genetic lottery. And I know what some of you are thinking. Playing God, unnatural. But I actually think the exact opposite is true. I can't think of anything that's more natural and more human than wanting to protect your child and wanting them to suffer less. We've just never had the information before, and now we do.

15:01Noor Siddiqui: I want to show you one last family. This is Lydia, Rohan and Jen's first child. She was born in a very serious neurodevelopmental disorder caused by a single base pair mutated in a gene called KCNQ2. They wanted a sister for Lydia, and they used ORCID for their next pregnancy. Lydia's newly minted younger sister, Lucy. Same parents, same love, different outcome. Not because of luck, because of a choice. Lucy won't become a patient before she becomes a person. She just gets to be a kid. And because of what her parents did, before she was born, she will. The future is not hypothetical. It is being born right now.

15:43Noor Siddiqui: This is the first generation who gets the genetic odds stacked in their favor. Thank you.

15:55So I'm going to put two questions into one that I'm guessing many people are asking. One, this isn't free. So you mentioned the genetic lottery, but does that stack the deck for those who have the ability for the resources? And then where do you draw the line? You kind of hinted in the end of superhuman sight or bones or endurance. Where would you draw that line with CRISPR and everything else?

16:17Noor Siddiqui: Yeah. So, yeah, I think that in terms of cost, you know, in contrast to what these diseases cost, it's actually, you know, pennies on the dollar, right? So the genetic condition that my mom has, retinitis pigmentosa, the first gene therapy that was approved costs a million dollars per eye. So in comparison, IVF and embryo screening is quite affordable. But yeah, in terms of where it goes, I mean, that's kind of why I'm here at TED. It's really up to you guys. Like, where do you guys want to see it go? I think that's going to be a really big societal conversation that needs to be had because the technology is moving so quickly and the capabilities are moving so quickly.

16:54A lot of food for thought. Thank you so much, Nora. Thank you. That was awesome. Thank you. Thanks.

17:02That was Noor Siddiqui at TED 2026. If you're curious about TED's curation, visit ted.com slash curation guidelines. And that's it for today. TED Talks Daily is a podcast from TED. This episode was fact-checked by the TED Research Team and produced and edited by our team, Martha Estefanos, Oliver Friedman, and Tansika Sungmarnivong. Additional support from Daniela Ballarezzo, Christopher Faze-Bogan, Valentina Bohanini, Banban Chang, Brian Green, and Lainey Lott. Learn more at podcasts.ted.com. I am Elise Hu. I'll be back tomorrow with a fresh idea for your feed. Thanks for listening.

17:53This episode is sponsored by Ashby. Every talk you hear on this show started as an idea, and every idea that actually gets built needs a team. Today's sponsor, Ashby, is the software that supports hiring for those ambitious teams. Ashby is the all-in-one recruiting platform used by the teams at Lovable, Notion, Plaid, and Clay. If you wish that AI could help you move faster through scheduling and scorecards, that you could find that silver medalist candidate from 18 months ago in a few seconds, or that you had better visibility into the state of your candidate pipeline, Ashby is for you. See why over 80 % of Forbes' top AI companies choose Ashby to hire the best talent.

18:33And visit www.ashbyhq.com slash TED. This episode of TED Talks Daily is brought to you by Apollo.io. We often talk about how great ideas can change the way we work, but turning ideas into action takes focus, and sometimes that focus gets lost in the busy work. For sales teams, finding the right people to connect with, reaching out, and keeping up with follow-ups can mean juggling multiple tools. Apollo.io brings prospecting, outreach, and follow-up together in one platform, helping sales teams find the right buyers and spend less time managing scattered tasks and more time building meaningful connections.

19:12Whether you're a small business or a part of a larger organization, Apollo.io helps bring more of your sales workflow into one place so your team can focus on the conversations that matter. Ready to take a closer look? Sign up for free at Apollo.io. That's Apollo.io.

19:32Grainger knows if you're a procurement manager at an industrial manufacturing facility, you're balancing inventory and budget while sourcing critical supplies across the operation. Too much inventory? Costs climb. Too little? Production slows. Grainger's$2 billion in on-hand inventory helps you get what you need when you need it, so you can help keep budgets balanced and lines moving. Call 1-800-GRAINGER, click grainger.com, or just stop by. Grainger, for the ones who get it done.